Product Images Eliquis

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Eliquis NDC 0003-0894 by E.r. Squibb & Sons, L.l.c., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Apixaban Chemical Structure - apixaban struct

Apixaban Chemical Structure - apixaban struct

eliquis 2.5 mg x 60s bottle - eliquis 2pt5mg 60slbl

eliquis 2.5 mg x 60s bottle - eliquis 2pt5mg 60slbl

This is a description of a medication called Eliquis in tablet form, containing 2.5mg of apixaban. Each bottle contains 60 tablets and the NDC code is 0003-0893-21. The instructions and dosages must be read on the package insert. The tablets should be stored at temperatures ranging from 20°C to 25°C. This medication is produced and marketed by Bristol-Myers Squibb Company.*

eliquis 5 mg x 60s bottle - eliquis 5mg 60slbl

eliquis 5 mg x 60s bottle - eliquis 5mg 60slbl

Eliquis is a medication available in the form of tablets that contain 5mg apixaban. It is a prescription-only medication that is distributed by Bristol-Myers Squibb Company in Princeton, USA, and Pizer Inc in NY, USA. The standard dosage of the medication should be taken as per the information provided in the package insert. The tablets should be stored between 20 to 25 degrees Celsius, and excursions between 15 to 50 degrees Celsius are allowed. Furthermore, it should not be used or taken if broken or missing.*

ARISTOTLE Forest Plot - eliquis clin forest fig5

ARISTOTLE Forest Plot - eliquis clin forest fig5

ARISTOTLE Major Bleeding Forest Plot - eliquis forest fig1

ARISTOTLE Major Bleeding Forest Plot - eliquis forest fig1

This is a table with data from a study comparing the effects of Apixaban and Warfarin on different subgroups of patients. The table shows the number of events and the number of patients (% per year). The subgroups are divided by different categories such as age, sex, weight, previous stroke or TIA, presence of diabetes, and CHADS, score among others. The risk ratio adjusted with 95% confidence intervals is also reported. However, the specific details and conclusions from the study are not available.*

ARISTOTLE Kaplan-Meier Curve - eliquis km fig4

ARISTOTLE Kaplan-Meier Curve - eliquis km fig4

Effect of Coadministered Drugs on Pharmacokinetics of Apixaban - eliquis pkplot drugs fig2

Effect of Coadministered Drugs on Pharmacokinetics of Apixaban - eliquis pkplot drugs fig2

The text describes the fold-change and 90% confidence interval for drug interactions with various inhibitors and inducers of P-gp and CYP3A4 enzymes. It includes the specific dosages of each medication and their effect on AUC (area under the curve). The drugs tested include Ketoconazole, Glarithromycin, Diltiazem, Naproxen, and Rifampin. The results show changes in AUC relative to a reference drug.*

O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08. PAS ESRD Dosing\01. Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg - eliquis pkplot pop fig3

O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08. PAS ESRD Dosing\01. Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg - eliquis pkplot pop fig3

eliquis 5 mg x 74 starter pack carton - eliquis starterpack 5mg74s carton

eliquis 5 mg x 74 starter pack carton - eliquis starterpack 5mg74s carton

This is a description of a Starter Pack for Eliquis (Apixaban) tablets that contains two wallets and is intended for use by the Westman and Pimonany Eolian. The pack includes 30-day supply of Eliquis tablets, with 5mg per tablet.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.